Tag: T2DM

ADA updates guideline for pharmacotherapy of T2DM

(HealthDay)—In a 2020 American Diabetes Association clinical guideline, published online Sept. 1 in the Annals of Internal Medicine, recommendations are presented for the pharmacologic treatment of adults with type 2 diabetes. Kacie Doyle-Delgado, D.N.P., from St. Mark’s Hospital and St. Mark’s Diabetes Center in Salt Lake City, and colleagues updated recommendations relating to the pharmacologic

WHO issues recommendations for Tx intensification in T2DM

(HealthDay)—Recommendations have been developed by the World Health Organization for treatment intensification in type 2 diabetes. The recommendations were published online Sept. 4 in the Annals of Internal Medicine. Gojka Roglic, M.D., and Susan L. Norris, M.D., M.P.H., from the World Health Organization in Switzerland, developed recommendations to provide guidance on medicine selection for treatment

Inverse link for plasma 25(OH)D concentration, risk of T2DM

(HealthDay)—There is an inverse association for plasma 25-hydroxyvitamin D (25[OH]D) concentration with diabetes risk, according to a study published online April 19 in PLOS ONE. Sue K. Park, M.D., Ph.D., from the Seoul National University College of Medicine in South Korea, and colleagues performed a cohort study involving 903 adults who were known to be

Community health worker-led intervention beneficial in T2DM

(HealthDay)—A community health worker (CHW)-led diabetes self-management education (DSME) program is associated with sustained improvement in hemoglobin A1c (HbA1c), according to a study published online April 27 in Diabetes Care. Michael S. Spencer, Ph.D., from the University of Michigan in Ann Arbor, and colleagues randomized 222 Latino adults with type 2 diabetes and poor glycemic